Qube Research & Technologies LTD Palatin Technologies Inc Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$0.37 - $0.54 $21,150 - $30,868	-57,164 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$0.34 - $0.86 $19,435 - $49,161	57,164 New	57,164 $29,000
Q1 2021 May 14, 2021	SELL	$0.68 - $1.25 $129,814 - $238,630	-190,904 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$0.38 - $0.78 $1,472 - $3,023	-3,876 Reduced 1.99%	190,904 $129,000
Q3 2020 Nov 12, 2020	SELL	$0.47 - $0.64 $132,760 - $180,780	-282,470 Reduced 59.19%	194,780 $92,000
Q2 2020 Aug 14, 2020	BUY	$0.41 - $0.73 $195,672 - $348,392	477,250 New	477,250 $244,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.64M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.